XML 49 R38.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Organization and Nature of Operations (Details) - Schedule of Condensed Consolidated Financial Statements - Avalon GloboCare Corp [Member] | 6 Months Ended
--- | ---
Jun. 30, 2024
Avalon Healthcare System, Inc. (“AHS”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | May 18, 2015
Percentage of Ownership | 100.00%
Principal Activities | Holding company for payroll and other expenses
Avalon RT 9 Properties LLC (“Avalon RT 9”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Feb. 07, 2017
Percentage of Ownership | 100.00%
Principal Activities | Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Apr. 29, 2016
Percentage of Ownership | 100.00%
Principal Activities | Is not considered an operating entity
Genexosome Technologies Inc. (“Genexosome”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Jul. 31, 2017
Percentage of Ownership | 60.00%
Principal Activities | No current activities to report, dormant
Avactis Biosciences Inc. (“Avactis”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Jul. 18, 2018
Percentage of Ownership | 60.00%
Principal Activities | Dormant, is in process of being dissolved
Avactis Nanjing Biosciences Ltd. (“Avactis Nanjing”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | May 08, 2020
Percentage of Ownership | 100.00%
Principal Activities | Dormant, is in process of being dissolved
Avalon Laboratory Services, Inc. (“Avalon Lab”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Oct. 14, 2022
Percentage of Ownership | 100.00%
Principal Activities | Laboratory holding company with a 40% membership interest in Lab Services MSO
Q&A Distribution LLC (“Q&A Distribution”) [Member] |
Schedule of Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | May 01, 2024
Percentage of Ownership | 100.00%
Principal Activities | Distributes KetoAir device

X
- Definition Description of business purpose of the subsidiary of the limited liability company or limited partnership, for example, its day-to-day operating functions and whether it acts as a holding or operating company. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date the subsidiary of the limited liability company (LLC) or limited partnership (LP) was formed, in YYYY-MM-DD format. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=avco_AvalonGloboCareCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonHealthcareSystemIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonRT9PropertiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonShanghaiHealthcareTechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_GenExosomeTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvactisBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvactisNanjingBiosciencesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonLaboratoryServicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_QADistributionLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |